Abstract

Aiwha Ong and Nancy Chen’s anthology Asian Biotech (Duke, 2010) wonderfully and incisively captures the initial results of a period of intense investment throughout much of Northeast, South and Southeast Asia in the most recent two to three decades in the emerging biosciences, grouping its collection of papers according to broad thematic clusters. Documenting a series of diverse, changing practices with respect to the use of bodies and human tissues in clinical trials, the related establishment of blood and tissue storage facilities, and even cutting-edge efforts to work with HESC technologies, the volume offers a comprehensive view of a rapidly emerging field in a part of the world that has only recently begun to appear as a major contributor to global techno-scientific activity, with state actors frequently leading the mobilization efforts. Juxtaposed against this thematic content, this review seeks to place the volume in conversation with a longer history, especially existing work in the history of the life sciences, which has until now been dominated by accounts of laboratories primarily based in the West. Rich with implications for a changing ethical practice driven by material changes in medical and scientific practice, Asian Biotech initiates any number of debates to open up a new field of inquiry.